Inventor · disambiguated record
Michael John Scott Saunders
Also filed as: SAUNDERS MICHAEL · SAUNDERS MICHAEL JOHN SCOTT
38 granted patents·19 pending applications·299 citations·filing 1991–2025
97Inventor score
Top patents by PatentIndex Score
57 records- 0195US8907065B2Polypeptides that modulate the interaction between cells of the immune systemHERMANS GUY·Filed 2007·Granted Dec 9, 2014·49 cites·34 claims
- 0294US9765149B2Antibodies to CD70ARGEN-X N V·Filed 2014·Granted Sep 19, 2017·24 cites·22 claims
- 0394US9765148B2Antibodies to CD70SILENCE KAREN·Filed 2012·Granted Sep 19, 2017·32 cites·13 claims
- 0494US8834882B2Antibodies to CD70SILENCE KAREN·Filed 2013·Granted Sep 16, 2014·30 cites·12 claims
- 0593US10844123B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2018·Granted Nov 24, 2020·4 cites·25 claims
- 0693US10087251B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2016·Granted Oct 2, 2018·9 cites·21 claims
- 0793US8557965B2Single variable domains against notch pathway membersSAUNDERS MICHAEL JOHN SCOTT·Filed 2009·Granted Oct 15, 2013·45 cites·13 claims
- 0890US9193780B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesHULTBERG ANNA·Filed 2009·Granted Nov 24, 2015·21 cites·19 claims
- 0989US10208115B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2016·Granted Feb 19, 2019·5 cites·25 claims
- 1089US9631027B2Anti c-Met antibodiesARGEN-X N V·Filed 2015·Granted Apr 25, 2017·7 cites·25 claims
- 1189US9005963B2Amino acid sequences directed against cellular receptors for viruses and bacteriaBLANCHETOT CHRISTOPHE·Filed 2009·Granted Apr 14, 2015·13 cites·18 claims
- 1289US8906680B2Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disordersBLANCHETOT CHRISTOPHE·Filed 2007·Granted Dec 9, 2014·11 cites·34 claims
- 1389US8637027B2Anti c-Met antibodiesHULTBERG ANNA·Filed 2011·Granted Jan 28, 2014·12 cites·21 claims
- 1489US2024182575A1Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2023·Application pending·0 cites
- 1583US11434298B2Antibodies to CD70argenx BV·Filed 2019·Granted Sep 6, 2022·1 cites·11 claims
- 1683US11072665B2Antibodies to CD70ARGENX BVBA·Filed 2015·Granted Jul 27, 2021·2 cites·39 claims
- 1783US9688773B2C-Met antibody combinationsHULTBERG ANNA·Filed 2011·Granted Jun 27, 2017·5 cites·20 claims
- 1882US9884917B2Anti c-Met antibodiesARGEN X N V·Filed 2013·Granted Feb 6, 2018·4 cites·9 claims
- 1982US9156914B2Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disordersBLANCHETOT CHRISTOPHE·Filed 2007·Granted Oct 13, 2015·4 cites·10 claims
- 2081US2023265201A1Antibodies to cd70argenx BV·Filed 2022·Application pending·0 cites
- 2180US10829552B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2018·Granted Nov 10, 2020·1 cites·14 claims
- 2280US9803018B2Amino acid sequences directed against cellular receptors for viruses and bacteriaABLYNX NV·Filed 2015·Granted Oct 31, 2017·2 cites·14 claims
- 2380US9212226B2Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the sameBLANCHETOT CHRISTOPHE·Filed 2009·Granted Dec 15, 2015·5 cites·12 claims
- 2479US10696741B2Anti-IL-22R antibodiesARGENX BVBA·Filed 2019·Granted Jun 30, 2020·1 cites·23 claims
- 2579US9382333B2Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesisABLYNX NV·Filed 2014·Granted Jul 5, 2016·3 cites·11 claims
- 2676US11858997B2Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2020·Granted Jan 2, 2024·0 cites·21 claims
- 2776US10017568B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using sameROMMELAERE HEIDI·Filed 2012·Granted Jul 10, 2018·3 cites·13 claims
- 2876US2025388700A1Variant fc regionsargenx BV·Filed 2025·Application pending·0 cites
- 2976US2025388699A1Variant fc regionsargenx BV·Filed 2025·Application pending·0 cites
- 3075US2023088269A1Anti-il-22r antibodiesARGENX BVBA·Filed 2022·Application pending·0 cites
- 3174US2022195031A1Amino acid sequences directed against il-17a, il-17f and/or il-17a/f and polypeptides comprising the sameMERCK PATENT GMBH·Filed 2022·Application pending·0 cites
- 3273US9688774B2Anti c-Met antibodiesARGEN-X N V·Filed 2015·Granted Jun 27, 2017·1 cites·24 claims
- 3372US11773159B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2020·Granted Oct 3, 2023·0 cites·15 claims
- 3471US11066473B2Galectin-10 antibodiesARGENX IIP BV·Filed 2019·Granted Jul 20, 2021·1 cites·24 claims
- 3571US8858940B2Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesisGONZALEZ PAJUELO MARIA·Filed 2009·Granted Oct 14, 2014·2 cites·11 claims
- 3671US2024026010A1Galectin-10 antibodiesargenx BV·Filed 2023·Application pending·0 cites
- 3770US11230603B2Anti-GARP proteinLUDWIG INST FOR CANCER RES LTD·Filed 2020·Granted Jan 25, 2022·0 cites·15 claims
- 3869US11447544B2Anti-IL-22R antibodiesargenx BV·Filed 2019·Granted Sep 20, 2022·0 cites·26 claims
- 3969US11261246B2Anti-IL-22R antibodiesARGENX BVBA·Filed 2019·Granted Mar 1, 2022·0 cites·23 claims
- 4067US10676535B2Anti c-Met antibodiesARGENX BVBA·Filed 2017·Granted Jun 9, 2020·0 cites·10 claims
- 4166US10604579B2Antibody against a complex between human GARP and latent TGF-βLUDWIG INST FOR CANCER RES LTD·Filed 2018·Granted Mar 31, 2020·0 cites·5 claims
- 4266US2015266958A1Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2014·Application pending·0 cites
- 4361US2017349667A1C-met antibody combinationsARGENX SE·Filed 2017·Application pending·0 cites
- 4459US11713354B2Galectin-10 antibodiesARGENX IIP BV·Filed 2021·Granted Aug 1, 2023·0 cites·15 claims
- 4557US2010136018A1Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic useABLYNX NV·Filed 2007·Application pending·0 cites
- 4656US2011262427A1Amino acid sequences that modulate the interaction between cells of the immune systemABLYNX NV·Filed 2011·Application pending·0 cites
- 4755US2022177604A1ANTI-IgE ANTIBODIESARGENX IIP BV·Filed 2020·Application pending·0 cites
- 4855US2016251438A1Anti-garp protein and uses thereofARGEN-X N V·Filed 2016·Application pending·0 cites
- 4954US9822175B2Amino acid sequences directed against the angiopoietin/tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesisABLYNX NV·Filed 2016·Granted Nov 21, 2017·0 cites·11 claims
- 5049US2011294982A1Amino acid sequences directed against integrins and uses thereofVANLANDSCHOOT PETER·Filed 2009·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael John Scott Saunders files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →